Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE study

Tamoxifen has been shown to greatly reduce risk of recurrence and contralateral breast cancer (CBC). Still, second primary contralateral breast cancer is the most common malignancy to follow a first primary breast cancer. Genetic variants in CYP2D6 and other drug-metabolizing enzymes that alter the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Brooks, Jennifer D, Teraoka, Sharon N, Malone, Kathleen E, Haile, Robert W, Bernstein, Leslie, Lynch, Charles F, Mellemkjær, Lene, Duggan, David J, Reiner, Anne S, Concannon, Patrick, Schiermeyer, Katherine, Lewinger, Juan Pablo, Bernstein, Jonine L, Figueiredo, Jane C
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3612453/
https://ncbi.nlm.nih.gov/pubmed/23565321
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados